The role of asparaginase in the treatment of ALL 

Nicolas Boissel, MD, PhD, Saint-Louis Hospital, Paris, France, discusses the role of asparaginase in the treatment of acute lymphoblastic leukemia (ALL), highlighting that the agent is an integral part of the chemotherapy backbone for adolescent and adult patients with the disease. This interview took place at the 29th Congress of the European Hematology Association (EHA) in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.